Roisín M. Connolly
- Family Practice top 2%
- Oncology top 2%
- Cancer Treatment and Pharmacology 20
- HER2/EGFR in Cancer Research 13
- Cancer Immunotherapy and Biomarkers 11
- Cancer Research top 5%
- Breast Cancer Treatment Studies 16
- Cancer Genomics and Diagnostics 8
- Psychiatry and Mental health top 5%
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 14
-
- Advanced Breast Cancer Therapies 16
-
- Estrogen and related hormone effects 9
- Co-authors
- Thomas I. BarronKathleen BennettVered StearnsKala VisvanathanLinda SharpAntonio C. WolffSaraswati SukumarMaria Cristina Figueroa Magalhães
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Roisín M. Connolly
99 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 127
- Family Practice 130
- Oncology 1.2k
- Cancer Research 610
- Psychiatry and Mental health 417
- Molecular Biology 1.2k
Countries citing papers authored by Roisín M. Connolly
This map shows the geographic impact of Roisín M. Connolly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roisín M. Connolly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roisín M. Connolly more than expected).
Fields of papers citing papers by Roisín M. Connolly
This network shows the impact of papers produced by Roisín M. Connolly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roisín M. Connolly. The network helps show where Roisín M. Connolly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roisín M. Connolly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 76 | |
| 10 | 2019 | 23 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 22 | |
| 13 | 2018 | 61 | |
| 14 | 2018 | 13 | |
| 15 | 2017 | 29 | |
| 16 | 2016 | 37 | |
| 17 | E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. | 2015 | 9 |
| 18 | Postmenopausal hormone receptor-positive advanced breast cancer. | 2013 | 6 |
| 19 | 2011 | 428 | |
| 20 | Detection of Spiked Uveal Melanoma Cells in Peripheral Blood of Healthy Volunteers | 2003 | 2 |
About Roisín M. Connolly
Roisín M. Connolly is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 105 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Advanced Breast Cancer Therapies (16 papers), Breast Cancer Treatment Studies (16 papers), Histone Deacetylase Inhibitors Research (14 papers), HER2/EGFR in Cancer Research (13 papers), Cancer Immunotherapy and Biomarkers (11 papers), Estrogen and related hormone effects (9 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Family Practice (130 citations), Oncology (1.2k citations) and Cancer Research (610 citations). Roisín M. Connolly has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Thomas I. Barron, Kathleen Bennett, Vered Stearns, Kala Visvanathan, Linda Sharp, Antonio C. Wolff, Saraswati Sukumar, Maria Cristina Figueroa Magalhães, Nguyen K. Nguyen and Danijela Jelovac.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.